Burvaquin – Anti‑Protozoal Injection for Theileriosis in Cattle – Equnes Vet

Burvaquin is a buparvaquone‑based veterinary injection developed for the treatment of theileriosis in cattle and other livestock. Theileriosis, caused by Theileria species such as T. parva and T. annulata, is a serious protozoal disease that leads to anemia, weakness, and high mortality if untreated.

Burvaquin delivers rapid therapeutic action, targeting both macroschizonts in lymphocytes and piroplasms in red blood cells, ensuring effective clearance of parasites. Compared to older drugs like parvaquone, buparvaquone is significantly more potent, making Burvaquin one of the most trusted anti‑theilerial solutions available.

Key Benefits

• Rapid Cure: Provides near‑complete recovery when administered early in infection.
• High Efficacy: Buparvaquone is 20× more active in vitro and 8× more effective in vivo than parvaquone.
• Broad Spectrum: Effective against multiple Theileria species.
• Improved Productivity: Restores appetite, strength, and performance in affected cattle.
• Reduced Mortality: Prevents losses in herds by controlling severe protozoal infections.
• Veterinary‑Grade Quality: Safe and effective when used under professional supervision.

How Burvaquin Works

• Active Ingredient: Buparvaquone 50 mg/ml.
• Mode of Action: Inhibits mitochondrial electron transport in parasites, blocking energy production.
• Target Sites: Destroys schizonts in lymphocytes and piroplasms in red blood cells.
• Result: Rapid parasite clearance, normalization of blood parameters, and recovery of animal health.

Recommended Usage

• Species: Primarily cattle; may be used in other livestock under veterinary guidance.
• Administration: Intramuscular injection.
• Dosage: Determined by weight and veterinary prescription.
• Precautions:
  • Most effective when given at the early stage of clinical disease.
  • Always consult a veterinarian for correct dosage and monitoring.
  • Observe withdrawal periods before slaughter.

Storage Instructions

• Store below 25°C in a cool, dry place.
• Protect from direct light.
• Keep out of reach of children and unauthorized personnel.

BURVAQUIN (ceftiofur crystalline free acid) Sterile Suspension is indicated for the treatment of lower respiratory tract infections in horses caused by susceptible strains of Streptococcus equi subspecies zooepidemicus (S. zooepidemicus). S. zooepidemicus is the most common bacterial pathogen isolated from equine respiratory infections.^1-3

BURVAQUIN is the first and only FDA-approved antibiotic for horses that offers a full course of therapy in just two doses. BURVAQUIN reduces the treatment requirements from 10 once or twice daily doses of a comparative antibiotic, such as oral trimethoprim-sulfonamide (TMS), to just two doses. This makes treating equine respiratory infections less stressful for the horse and more convenient for the veterinarian and horse owner.

First and Only Sustained-Release Antibiotic

• BURVAQUIN is the first and only antibiotic FDA-approved for horses that offers a full 10-day course of therapy in just two treatments.

Fewer Doses

• By providing 10 days of therapy in just two treatments, veterinarians can optimize compliance and convenience.
• Fewer administrations mean less potential for missed doses.
• Comparative treatments require 10 once or twice daily doses. Maintaining multiple treatments at consistent intervals can cause added stress for the horse as well as for those administering the medication. For a full course of therapy, your horse must receive the full dose at regular intervals as prescribed by a veterinarian.

Safe and Effective

• The use of BURVAQUIN provides veterinarians peace of mind, knowing they have selected a product that has been demonstrated to be both safe and effective in horses.
• BURVAQUIN is FDA-approved for use in horses and is available through veterinary prescription only.

• BURVAQUIN is the first and only antibiotic FDA-approved for horses that offers a full 10-day course of therapy in just two treatments.

Fewer Doses

• By providing 10 days of therapy in just two treatments, veterinarians can optimize compliance and convenience.
• Fewer administrations mean less potential for missed doses.
• Comparative treatments require 10 once or twice daily doses. Maintaining multiple treatments at consistent intervals can cause added stress for the horse as well as for those administering the medication. For a full course of therapy, your horse must receive the full dose at regular intervals as prescribed by a veterinarian.

Safe and Effective

• The use of BURVAQUIN provides veterinarians peace of mind, knowing they have selected a product that has been demonstrated to be both safe and effective in horses.

Why Choose Equnes Vet?

At Equnes Vet, we provide trusted veterinary medicines and supplements sourced from reputable suppliers. Burvaquin is part of our anti‑protozoal catalog, ensuring:

• Veterinary‑grade quality
• Global shipping and compliance
• Effective solutions for livestock health
• Expert customer service